$53.97
0.110.20%
$53.97
0.110.20%
Royalty Pharma PLC Earnings Estimates
RPRXNASDAQ
Royalty Pharma Earnings Estimates, EPS & Revenue | NASDAQ:RPRX
Royalty Pharma (RPRX) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $1.27 and quarterly revenue of $797.26M.
In the most recent quarter (Q1), Royalty Pharma reported EPS of $1.30, beating estimates of $1.19 by 0.09%. Revenue came in at $631.00M, missing the estimate of $877.54M by 0.28%.
Royalty Pharma has beaten EPS estimates in 7 consecutive quarters.
Over the last 4 quarters, Royalty Pharma has averaged an EPS surprise of 0.09% and a revenue surprise of 0.23%.
Earnings Date
Aug 5
EPS Estimate
$1.270
Quarterly Revenue Estimate
$797.26M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.44B
Royalty Pharma Earnings History
Analyze the earnings history of Royalty Pharma using advanced sorting and filters.
Loading calendar...
Royalty Pharma (RPRX) Earnings Per Share
The chart below shows Royalty Pharma's reported EPS compared to analyst estimates over recent quarters.
Royalty Pharma (RPRX) Revenue
The chart below shows Royalty Pharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Royalty Pharma (NASDAQ:RPRX) reporting earnings?
Royalty Pharma (RPRX) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 6, 2026 for Q1.
What were the latest earnings per share (EPS) for Royalty Pharma (NASDAQ:RPRX)?
The Actual EPS was $1.30, which beat the estimate of $1.19.
What were Royalty Pharma’s (NASDAQ:RPRX) revenues?
The Actual Revenue was $631.00M, which missed the estimate of $877.54M.
